← SynDRA
SYN0870233
SynDRA canonical compound SYN0870233 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PKD1 |
|---|
| Mechanism of action | protein kinase inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- APEX1
- BAZ2B
- CBX1
- EHMT2
- MAPT
- MBNL1
- NFE2L2
- TDP1
Cross-references
Synonyms
- CID-2011756
- MLS000557592
- MFCD04094273
- SMR000148508
- C22H21ClN2O3
- Oprea1_481390
- orb1307300
- SCHEMBL17373218
- SCHEMBL30417288
- BDBM32341
- cid_2011756
- EX-A263
- GLXC-02609
- HMS2426M13
- AIA95439
- s5792
- STL289952
- AKOS003197082
- CS-1676
- NCGC00370746-10
- AC-35203
- AS-16525
- DA-34978
- HY-13454
- ST51028822
- AP-970/41680438
- CID-2011756, >=98% (HPLC)
- F468326
- 5-(3-chlorophenyl)-N-[4-(morpholinomethyl)phenyl]-2-furamide
Look up SYN0870233 in the interactive SynDRA portal →